Skip to main content
Equibles

PRELUDE CAPITAL MANAGEMENT, LLC

Position in COYA — Coya Therapeutics, Inc.

CIK 1387508 NEW YORK, NY
Back to COYA Full portfolio

Position in COYA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$592,780
+$193,540 QoQ
Shares Held
101,330
0.0% QoQ
Ownership
0.432%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#15
of 54 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in COYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $43,640,056 across 72 Biotechnology names. COYA ranks #12 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1
58,590 $7,776,650
2 TECH
BIO-TECHNE Corp
 91,696 $6,478,322
3 PGEN
Precigen, Inc.
 882,267 $5,028,921
4 ROIV
Roivant Sciences Ltd.
 113,104 $4,002,750
5 RVMD
Revolution Medicines, Inc.
 10,997 $2,059,518
6 TWST
Twist Bioscience Corp
 18,976 $1,952,250
7 QURE
uniQure N.V.
 32,229 $1,484,467
8 MDXG
Mimedx Group, Inc.
 215,239 $828,670

All Filings in COYA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $592,780 101,330
2026-03-31 $399,240 101,330
2025-12-31 $303,166 52,270
2025-09-30 $203,889 35,770
2025-06-30 $205,677 35,770
2025-03-31 $231,431 35,770
2024-12-31 $204,962 35,770
2024-09-30 $230,716 35,770
2024-06-30 $216,766 35,770
2024-03-31 $354,838 35,770
2023-12-31 $265,055 35,770
2023-09-30 $137,356 35,770